A clinical trial from the University of Colorado Anschutz found oral semaglutide, the medication behind Ozempic and Wegovy used to treat diabetes and weight loss, can reduce heavy drinking in adults ...

The 24-week clinical trial will track more than 600 veterans nationwide to observe if the medication reduces alcohol cravings ...

A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with alcohol use disorder ...

A nationwide US trial is testing semaglutide to reduce alcohol consumption, potentially offering the first breakthrough in ...

The VA Medical Center in Dallas is participating in a nationwide clinical trial to determine if Semaglutide injections can ...

The first published evidence from humans that semaglutide specifically reduces the symptoms of alcohol use disorder (AUD) has been published in The Journal of Clinical Psychiatry and details a recent ...

A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy drinking in adults with Alcohol Use Disorder ...

People with alcohol use disorder who took semaglutide, also known as Wegovy, drank less and had fewer cravings for alcohol, new research found. Reading time 3 minutes A study out this week suggests ...

A phase 2, randomized, double-blind trial (N=50) used oral semaglutide 3 mg/day then 7 mg/day, combining cue-reactivity testing with Timeline Follow-Back naturalistic drinking assessment and objective ...

A man prescribed semaglutide for obesity saw his drinking fall dramatically over 10 months, adding fresh real-world evidence to the idea that GLP-1 drugs may help curb alcohol cravings while ...

A new study showed that semaglutide may help with alcohol use disorder Steve Christo - Corbis/Corbis via Getty; Getty A new study (the first clinical trial of its kind) has shown that the GLP-1 ...

AURORA, Colo., July 29, 2026 /PRNewswire/ -- A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and weight loss, reduces heavy ...